Patents Assigned to Klaus Keplinger
  • Patent number: 5302611
    Abstract: Tetra- and pentacyclic oxindole alkaloids, in particular the alloisopteropodine, isomer A, a pentacyclic oxindole alkaloid, are suitable for the unspecific stimulation of the immunologic system, which has been proved by a substantial percental phagocytosis increase in the granulocytic test according to BRANDT (in vitro), a substantial percental increase of the CL-response in the chemiluminescence test (in vitro) and a high increase of the phagocytosis activity of tissue macrophages of the reticoloendothelial system in the carbon-clearence-test (CCT) according to BIOZZI.
    Type: Grant
    Filed: September 30, 1992
    Date of Patent: April 12, 1994
    Assignee: Klaus Keplinger
    Inventors: Klaus Keplinger, Dietmar Keplinger
  • Patent number: 4940725
    Abstract: Tetra- and pentacyclic oxindole alkaloids, in particular the alloisopteropodine, isomer A, a pentacyclic oxindole alkaloid, are suitable for the unspecific stimulation of the immunologic system, which has been proved by a substantial percental phagocytosis increase in the granulocytic test according to BRANDT (in vitro), a substantial percental increase of the CL-response in the chemiluminescence test (in vitro) and a high increase of the phagocytosis activity of tissue macrophages of the reticoloendothelial system in the carbon-clearence-test (CCT) according to BIOZZI.
    Type: Grant
    Filed: April 3, 1989
    Date of Patent: July 10, 1990
    Assignee: Klaus Keplinger
    Inventors: Klaus Keplinger, Hildebert Wagner, Barbara Kreutzkamp
  • Patent number: 4844901
    Abstract: Tetra- and pentacyclic oxindole alkaloids, in particular the alloisopteropodine, isomer A, a pentacyclic oxindole alkaloid, are suitable for the unspecific stimulation of the immunologic system, which has been proved by a substantially percental phagocytosis increase in the granulocytic test according to BRANDT (in vitro), a substantial percental increase of the CL-response in the chemiluminescence test (in vitro) and a high increase of the phagocytosis activity of tissue macrophages of the reticoloendothelial system in the carbon-clearence-test (CCT) according to BIOZZI.
    Type: Grant
    Filed: May 16, 1988
    Date of Patent: July 4, 1989
    Assignee: Klaus Keplinger
    Inventors: Klaus Keplinger, Hildebert Wagner, Barbara Kreutzkamp